Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gaming Naltrexone Eye Tracking
NCT04649892Phase 2Recruiting
- Sponsor
- Universidade de São Paulo
- Start
- Jul 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in Gaming Disorder (IGD), sponsored by Universidade de São Paulo. Started Jul 2026; status: recruiting.
02
Drugs
naltrexone
03
Conditions
Gaming Disorder (IGD)
Beyond the preview
Go deeper on NCT04649892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04649892.